NSDL IPO & Share Price Today: GMP, Valuation & Should You Subscribe?

NSDL’s long-awaited IPO—a ₹4,012 crore pure offer-for-sale—opened on 30 July at a price band of ₹760–₹800, backed by solid investor interest with a ~16% grey market premium signaling healthy listing gains.

Background: What Is NSDL?

National Securities Depository Limited (NSDL), established in 1996, was India’s first electronic securities depository and is currently the nation’s premier infrastructure provider for dematerialized securities. Managing corporate bonds, mutual funds, and demat settlements, NSDL’s assets under custody exceed ₹400 lakh crore .

IPO Overview: Price Band & Details

The IPO launched on 30 July 2025, closing on 1 August, via pure Offer-for-Sale (OFS) of ~5.01 crore shares by existing shareholders including NSE and banks, with no fresh capital raised .
Price band was fixed between ₹760 and ₹800 per share, valuing the issue at approximately ₹4,011 crore .

Grey Market Premium (GMP): Live Update & Implications

GMP was trading at ₹126–₹135, indicating listing gains of around 16%–17%, with estimated listing prices between ₹926–₹935 .

Such premium reflects strong pre-listing investor sentiment and liquidity expectation.

Day-1 Subscription Status & Market Response

By midday, total subscription reached ~0.8x, while retail investors subscribed ~0.87x, NIIs at ~0.97x, and QIBs only ~0.5x of quotas, with employees’ portion booked to ~158% .
Analysts maintained a “Subscribe for the Long Term” stance owing to NSDL’s institutional legacy, fee-based revenue model, and capital market infrastructure role

NSDL vs CDSL: Can History Repeat?

CDSL, India’s only other listed depository, has delivered ~12× returns since its 2017 listing .
However, NSDL manages fewer demat accounts (~3.95 crore vs. CDSL’s 15+ crore) but holds greater institutional asset base .
NSDL’s valuation is nearly half of CDSL’s market cap (~₹16,000 crore vs ₹32,000 crore), offering a discount despite larger scale .

Thus while historical returns inspire optimism, NSDL’s fundamentals must chart its future course.

Financial Metrics & Valuation

According to initial filings and live blogs:

Revenue (FY25): ₹1,420 crore, up ~12% YoY.
PAT (FY25): ₹343 crore, up ~25%.
EBITDA margin: ~34.7% .
Valuation multiples: P/E ~46.6×, P/B ~7.9× on FY25 numbers, compared to CDSL trades at P/E ~60× and P/B ~18× .

Investor Considerations: Strengths & Risks

Strengths

Crucial role in India’s financial infrastructure, offering annuity-style revenues.
High margins and revenue visibility, with negligible cyclicality.
Listing at a valuation discount to CDSL may offer upside potential with time.

Risks

Lower retail penetration and demat account base compared to CDSL.
Regulatory changes or competition from fintech entry could compress margins.
Grey market sentiment may not translate to long-term performance.

FAQs

Q1. What is grey market premium (GMP) and why does it matter?
GMP represents unofficial pricing ahead of IPO listing and reflects investor sentiment on expected listing price. For NSDL, a GMP of ₹126–₹135 suggests ~16% potential upside .

Q2. Is NSDL IPO worth subscribing given CDSL’s past performance?
While CDSL returned ~12x since listing, NSDL’s fundamentals, institutional credibility, and valuation discount offer a compelling long-term investment case.

Q3. What is the subscription status of NSDL IPO on Day 1?
By midday, total subscription was ~0.8x; retail ~0.87x, NII ~0.97x, QIB ~0.5x, and employee portion oversubscribed .

Q4. When is NSDL expected to list on stock exchanges?
Allotments are likely on 2 August 2025, with listing anticipated on 5 August on both NSE and BSE .

Latest Posts

Our previous related articles include:

Helpful Resources

Conclusion

NSDL’s IPO marks a key milestone in India’s capital markets infrastructure. With robust grey market signals, a reputable institutional pedigree, and disciplined financials, it offers investors a rare opportunity to access a nearly monopolistic financial backbone. However, cautious assessment of pricing and long-term growth prospects remains essential. For long-term investors, subscribing at the upper price band could be beneficial, but measured expectations must align with valuations.